The response deadline has passed. Review the details for future reference or to track similar opportunities.
The Department of Veterans Affairs is procuring Acamprosate Calcium Extended-Release Tablets for use in veteran substance use disorder treatment programs, requiring FDA-approved generic formulations with consistent bioequivalence, stable supply chain compliance, and adherence to VA formulary standards.
Procurement of FDA-approved extended-release Acamprosate Calcium tablets to support VA medical treatment programs for alcohol use disorder among veterans.
No description available
Get matched to contracts like this daily
Free AI-powered contract matching for your business.